Abstracts

Abstracts

Abstract submission was encouraged for the categories listed below. Abstract submission for the 2023 conference will open in the fourth quarter of 2022.

 

Abstract Types

Abstracts were accepted for Oral Presentation or Scientific Poster formats:

Oral Presentation: a standard scientific abstract considered for either an oral presentation, or a poster presentation. Authors indicated whether they want to be considered for either format, or only for oral presentation. These submissions were required to include complete objective, methods, results, and conclusions sections.

Scientific Poster: a standard scientific abstract submission for a poster presentation. These submissions were required to include complete objective, methods, results, and conclusions sections. All posters were presented electronically and authors also were expected to present a PDF poster file. Authors had the option to record a brief video as well. Authors of the poster abstracts with the highest peer review scores were invited to give lightning communication presentations (brief 2-3 minute oral presentations) in addition to presenting a PDF poster.

All submissions that were presented at the conference will be published in a special edition of Prenatal Diagnosis.
See previously published abstracts.

Abstracts are encouraged on the following topics. 

Abstract Categories

Abstract submissions were encouraged in the following categories.

  • Cytogenetics and Molecular Genetics
  • Epigenetics and development
  • Fetal and placental development and pathology
  • Fetal imaging: Ultrasound and Magnetic Resonance Imaging
  • Fetal medical and surgical therapy
  • Global issues in prenatal diagnosis and screening
  • Maternal serum/NT screening for aneuploidy
  • Noninvasive prenatal diagnosis and screening
  • Pre-implantation genetic diagnosis and screening
  • Prenatal diagnosis of single gene disorders / inborn errors of metabolism
  • Prenatal diagnostic procedures
  • Prenatal genetic counseling
  • Prenatal prediction of adverse pregnancy outcomes (e.g pre-eclampisa / preterm labour / growth restriction and stillbirth)
  • Psychosocial, legal and ethical issues in prenatal screening and diagnosis
  • Reproductive genomics, metabolomics and proteomics
  • Screening for single gene disorders
  • Teratogens and Fetal infection
  • Twins
  • Other
Published abstracts from previous years are available through the Downloads page.